www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHFri, 10 Jul 2026 21:07:04 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netThu, 09 Jul 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-conferences-in-july-15789257

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor Conferences in July 09.07.2026 / 12:30 CET/CEST The issuer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-conferences-in-july-15789257Wed, 10 Jun 2026 12:30:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-industry-and-scientific-conferences-in-june-15737479 Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor, Industry and Scientific Conferences in June 10.06.2026 / 12:30 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-industry-and-scientific-conferences-in-june-15737479Thu, 28 May 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-present-additional-phase-2-calliper-trial-data-for-vidofludimus-calcium-at-the-cmsc-annual-meeting-2026-reinforcing-its-potential-in-progressive-multiple-sclerosis-15714333 Issuer: Immunic AG / Key word(s): Conference/Study results Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-present-additional-phase-2-calliper-trial-data-for-vidofludimus-calcium-at-the-cmsc-annual-meeting-2026-reinforcing-its-potential-in-progressive-multiple-sclerosis-15714333Wed, 27 May 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-distinguished-biopharmaceutical-executive-erik-lundgren-as-chief-executive-officer-15711557 Issuer: Immunic AG / Key word(s): Personnel Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer 27.05.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-distinguished-biopharmaceutical-executive-erik-lundgren-as-chief-executive-officer-15711557Tue, 19 May 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-seasoned-biopharmaceutical-executive-michael-w-bonney-as-chair-of-the-board-of-directors-15697203 Issuer: Immunic AG / Key word(s): Personnel Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors 19.05.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-seasoned-biopharmaceutical-executive-michael-w-bonney-as-chair-of-the-board-of-directors-15697203Wed, 13 May 2026 12:30:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-reports-first-quarter-2026-financial-results-and-provides-corporate-update-15682082 Issuer: Immunic AG / Key word(s): Quarter Results Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update 13.05.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-reports-first-quarter-2026-financial-results-and-provides-corporate-update-15682082Thu, 30 Apr 2026 12:30:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-and-medical-conferences-in-may-15648215 Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor and Medical Conferences in May 30.04.2026 / 12:30 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-investor-and-medical-conferences-in-may-15648215Tue, 28 Apr 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-accomplished-biopharmaceutical-executive-michael-a-panzara-m-d-m-p-h-as-chief-medical-officer-15640484 Issuer: Immunic AG / Key word(s): Personnel Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-appoints-accomplished-biopharmaceutical-executive-michael-a-panzara-m-d-m-p-h-as-chief-medical-officer-15640484Thu, 23 Apr 2026 14:00:04 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-announces-1-for-10-reverse-stock-split-15630179 Issuer: Immunic AG / Key word(s): Statement Immunic, Inc. Announces 1-for-10 Reverse Stock Split 23.04.2026 / 14:00 CET/CEST The issuer ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-inc-announces-1-for-10-reverse-stock-split-15630179Thu, 09 Apr 2026 12:30:03 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-scientific-and-medical-conferences-in-april-15601496 Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Scientific and Medical Conferences in April 09.04.2026 / 12:30 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-immunic-to-participate-in-scientific-and-medical-conferences-in-april-15601496